EU ‘Big Data’ Report: Big Opportunities – And Big Challenges

EU regulators have produced the first fruits of their ambitious “big data” project aimed at ensuring that the EU drug regulatory system can make full use of the rapidly increasing volume and complexity of data being gathered across multiple settings in the healthcare area.

Big data
A new report outlines the opportunities and challenges of using big data in regulatory decision making • Source: Shutterstock

Big data will play a key role in regulatory procedures for developing, evaluating and monitoring the safety and effectiveness of medicines, medical devices and combinations of the two, and without it many future regulatory activities will not be possible.

However, many hurdles must still be overcome in areas like data access, transfer, interoperability and quality, and without a coordinated...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Europe

More from Geography